Repligen
RGEN
#2378
Rank
ยฃ5.92 B
Marketcap
ยฃ105.12
Share price
-5.34%
Change (1 day)
15.95%
Change (1 year)
Categories

Repligen (RGEN) - Total debt

Total debt on the balance sheet as of March 2026 : ยฃ0.51 Billion

According to Repligen 's latest financial reports the company's total debt is ยฃ0.51 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Repligen - Total debt on balance sheet (from 2004 to 2026)

Total debt by year

Year Total debt Change
2025-12-31ยฃ0.51 B-6.31%
2024-12-31ยฃ0.54 B-2.12%
2023-12-31ยฃ0.55 B59.81%
2022-12-31ยฃ0.34 B28.92%
2021-12-31ยฃ0.27 B34.21%
2020-12-31ยฃ0.20 B0.62%
2019-12-31ยฃ0.20 B146.3%
2018-12-31ยฃ81.52 M11.02%
2017-12-31ยฃ73.43 M-4.89%
2016-12-31ยฃ77.21 M
2005-03-31ยฃ0.06 M37.95%
2004-03-31ยฃ0.04 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
ยฃ48.14 B 9,168.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
ยฃ32.60 B 6,176.87%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
ยฃ15.31 B 2,848.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ35.07 B 6,651.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
ยฃ19.2 M-96.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
ยฃ0.22 B-57.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ0.30 B-40.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
ยฃ0.21 B-57.78%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ1.08 B 109.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
ยฃ2.30 B 344.47%๐Ÿ‡บ๐Ÿ‡ธ USA